Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer

Tanaka, H; Sase, H; Tsukaguchi, T; Hasegawa, M; Tanimura, H; Yoshida, M; Sakata, K; Fujii, T; Tachibana, Y; Takanashi, K; Higashida, A; Hasegawa, K; Ono, Y; Oikawa, N; Mio, T

Tanaka, H (reprint author), Chugai Pharmaceut Co Ltd, 200 Kajiwara, Kamakura, Kanagawa 2478530, Japan.

MOLECULAR CANCER THERAPEUTICS, 2018; 17 (12): 2519